PARP inhibitors for ovarian cancer

preview_player
Показать описание
Kathleen Moore, MD, Stephenson Cancer Center, Oklahoma City, OK, talks about the treatment landscape of ovarian cancer with the emergence of PARP inhibitors. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.
  1. VJOncology
  2. Speaker: Kathleen Moore
  3. Event: ESMO 2019
  4. Format: Interview
  5. Subject: Ovarian Cancer
  6. Subject: Gynecological Cancer
Рекомендации по теме
PARP inhibitors in 0:59:14

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023

PARP inhibitors for 0:03:45

PARP inhibitors for ovarian cancer

What’s New with 0:58:44

What’s New with PARP Inhibitors and Ovarian Cancer?

An Overview of 0:03:05

An Overview of PARP Inhibitors in Ovarian Cancer

Overcoming resistance to 0:01:22

Overcoming resistance to PARP inhibition in ovarian cancer

PARP Inhibitors for 0:01:26

PARP Inhibitors for Maintenance Therapy in Ovarian Cancer

Personalizing Advanced Ovarian 0:57:11

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

Updates in PARP 0:01:38

Updates in PARP inhibition for ovarian cancer

PARP Inhibition Improves 0:01:27

PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian Cancer

PARP Inhibitors for 0:08:41

PARP Inhibitors for Ovarian Cancer: Use of Olaparib

Recurrent Ovarian Cancer: 0:03:06

Recurrent Ovarian Cancer: Choosing a PARP Inhibitor

PARP Inhibitors for 0:34:17

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat

Assessing the role 0:02:38

Assessing the role of PARP inhibitors and immunotherapy in ovarian cancer

Ovarian Cancer: Recurrence 0:03:25

Ovarian Cancer: Recurrence After PARP Inhibition

Ovarian Cancer: Comparisons 0:07:09

Ovarian Cancer: Comparisons Between PARP Inhibitors

SOLO-1 and PARP 0:04:40

SOLO-1 and PARP Inhibitors in Ovarian Cancer

The Future Role 0:03:44

The Future Role of PARP Inhibition in Ovarian Cancer

PARP Inhibitors in 0:06:20

PARP Inhibitors in Recurrent Ovarian Cancer

Dr. Birrer on 0:01:49

Dr. Birrer on PARP Inhibitors in Ovarian Cancer

Dr. Berek Discusses 0:01:11

Dr. Berek Discusses the Impact of PARP Inhibitors on Ovarian Cancer

Dr. Konecny on 0:02:02

Dr. Konecny on Resistance to PARP Inhibitors in Ovarian Cancer

Optimizing the Use 1:10:07

Optimizing the Use of PARP Inhibitors in Ovarian Cancer

Combinations With PARP 0:06:25

Combinations With PARP Inhibitors for Ovarian Cancer

PARP inhibitor rechallenging 0:00:46

PARP inhibitor rechallenging in ovarian cancer